Watch CBSN Live

Coronavirus drug remdesivir comes at a cost for Americans

A five-day treatment of remdesivir, one of two known drugs proven to help treat COVID-19, will cost $3,120 for a typical U.S. patient with commercial insurance. Gilead Sciences, the drugmaker, has promised a lower “government price,” but that excludes Medicare and Medicaid. Dr. Shoshana Ungerleider joined CBSN to discuss the potential impact.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.